Latest Sanofi Stories
Globally, hyaluronic acid viscosupplementation products must rely on clinical efficacy, as healthcare practitioners are not particularly responsive to branding or purchasing incentives, according
Generics Division of Sanofi, Winthrop US, to Market the Drug BRIDGEWATER, N.J., Aug.
First shipment marks a critical step in improving access to treatment worldwide PARIS and SOUTH SAN FRANCISCO, Calif., Aug.
PARIS and VALENCIA, Calif., Aug.
PARIS, July 31, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014.
TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and
DALLAS, July 23, 2014 /PRNewswire/ -- Expiring biologic human insulin market drugs' patents are set to create new opportunities for biosimilar drugs, which is estimated
DUBLIN, July 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3txjqf/global_type_1) has announced the addition of the "Global
- The word or words serving to define another word or expression, as in a dictionary entry.